Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Comment by forhandlarenon Dec 01, 2020 3:39am
155 Views
Post# 32007375

RE:RE:RE:RE:Waxie...it's clear to me....

RE:RE:RE:RE:Waxie...it's clear to me....The chinese deals are to some extent based on personal relationship. I can understand the importance of Howard being part the business team. But it is not necessary that he is CEO. I think he is planning to step down as the company grows. When?

I really want a senior in charge of the business team before anti-aging is negotiated. Cannot afford this one to slip into a lame deal.

Based in Europe. Not sure how to vote at the AGM. I appreciate that at least someone voted against the board. A challenge is that Howard et al has a strong position versus the other shareholders and they grow stronger every year because of the options/warrents they hand out to themselves. 

For the record it seems like I was spot on for once  - we should not expect any NR before years end - but on the other hand it was a no brainer!
<< Previous
Bullboard Posts
Next >>